Sector consensus Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX 10:55:01 22/09/2026 pm IST			5-day change	1st Jan Change
287.66 ^USD	+3.10%		+5.47%	+44.29%

17/09	Charles River Laboratories International Introduces Rapid Cell Banking Programs with Next-Generation Sequencing Characterization	CI
17/09	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.			284.93	+2.12%	15
LONZA GROUP AG			688.17	+25.4%	23
IQVIA HOLDINGS INC.			277.94	+2.99%	18
REVOLUTION MEDICINES, INC.			253.21	+31.36%	20
BEONE MEDICINES AG			432.8	+18.36%	28
CELLTRION, INC.			2,67,786.94	+47.62%	22
MEDPACE HOLDINGS, INC.			581.83	-6.79%	12
ASCENDIS PHARMA A/S			272.18	+31.39%	20
EUROFINS SCIENTIFIC SE			72.24	-7.45%	14
TEMPUS AI, INC.			68.56	-12.14%	18
ICON PUBLIC LIMITED COMPANY			185.25	+9.26%	16
BIO-TECHNE CORPORATION			70.73	-2.4%	11
PHARMARON BEIJING CO., LTD.			50.57	+12.06%	11
KYMERA THERAPEUTICS, INC.			138.64	+17.82%	22
PROTAGONIST THERAPEUTICS, INC.			174.69	+20.49%	13
ABIVAX			137.98	+52.21%	7
QIAGEN N.V.			46.27	+3.32%	15
PRAXIS PRECISION MEDICINES, INC.			638.68	+113.7%	19
IMMUNOVANT, INC.			48.88	+31.46%	16
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.	-	-	53.66	-9.53%	1
Average			13,613.21	+19.06%	16
Weighted average by Cap.			21,679.24	+18.93%	19